Baudax Bio, Inc. Gains 50.67%
Thu, Sep 28, 2023 at 07:36 PM
Baudax Bio, Inc. (BXRX:NASDAQ) soared at $0.45, representing a gain of 50.7%. On Thu, Sep 28, 2023, BXRX:NASDAQ touched a New 2-Week High of $0.45. The stock appeared on our News Catalysts scanner on Thu, Sep 28, 2023 at 09:59 AM in the 'BIOTECH' category. From Thu, Sep 14, 2023, the stock recorded 20.00% Up Days and 27.27% Green Days
The stock spiked on Thu, Sep 28, 2023 at $0.78 with a volume of 167M+.
About Baudax Bio, Inc. (BXRX:NASDAQ)
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings.
Top 10 Gainers:
- Bionomics Limited (BNOX:NASDAQ), 243.84%
- Digital Transformation Opportunities Corp. (DTOC:NASDAQ), 89.56%
- Chico's FAS, Inc. (CHS:NYSE), 63.12%
- Axcella Health Inc. (AXLA:NASDAQ), 52.97%
- Baudax Bio, Inc. (BXRX:NASDAQ), 50.67%
- Aytu BioScience, Inc. (AYTU:NASDAQ), 39.06%
- Sarcos Technology and Robotics Corporation (STRC:NASDAQ), 37.31%
- Femasys Inc. (FEMY:NASDAQ), 36.94%
- Vaccinex, Inc. (VCNX:NASDAQ), 34.82%
- Infinity Pharmaceuticals, Inc. (INFI:NASDAQ), 34.4%